文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

抑制有氧糖酵解通过CXCR2促进脓毒症中性粒细胞向感染部位浸润

Inhibition of Aerobic Glycolysis Promotes Neutrophil to Influx to the Infectious Site Via CXCR2 in Sepsis.
PubMed 文献 · Shock · 2020-01-01
一句话结论小鼠脓毒症模型中,糖酵解抑制剂2-DG提高生存率、增加中性粒细胞向感染部位迁移并增强细菌清除,该保护效应部分由CXCR2介导。

该研究在盲肠结扎穿孔(CLP)诱导的脓毒症小鼠中发现,糖酵解抑制剂2-脱氧葡萄糖(2-DG)显著提高生存率,并增加中性粒细胞向感染部位迁移、增强细菌清除。2-DG可逆转CLP小鼠或脂多糖(LPS)处理人中性粒细胞中趋化因子受体2(CXCR2)的下调和趋化功能受损。机制上,2-DG通过抑制细胞外调节蛋白激酶(ERK)磷酸化、促进P38磷酸化,降低G蛋白偶联受体激酶-2(GRK2)表达,从而逆转CXCR2下调。CXCR2拮抗剂SB225002部分阻断2-DG的保护作用,提示有氧糖酵解可能是脓毒症的潜在干预靶点。

要点

  • 在CLP诱导的脓毒症小鼠中,2-DG显著提高生存率,并增加中性粒细胞向感染部位迁移、增强细菌清除。
  • 2-DG可逆转CLP小鼠中性粒细胞及LPS处理的人中性粒细胞中CXCR2下调和趋化功能受损。
  • 2-DG通过抑制ERK磷酸化、促进P38磷酸化降低GRK2表达,从而逆转中性粒细胞CXCR2下调。
  • CXCR2拮抗剂SB225002可部分阻断2-DG在脓毒症中的保护作用,提示CXCR2参与该效应。
  • 作者认为有氧糖酵解可能是脓毒症的潜在干预靶点。

适用人群与场景

  • CLP诱导的脓毒症小鼠;体外LPS处理的人中性粒细胞。

研究设计与关键结果

  • 研究类型为动物实验与体外细胞实验;在CLP诱导的脓毒症小鼠中,糖酵解抑制剂2-DG显著提高生存率。
  • 2-DG处理小鼠较未处理小鼠中性粒细胞向感染部位迁移增加、细菌清除更有效。
  • 2-DG逆转CLP小鼠中性粒细胞及LPS处理人中性粒细胞中CXCR2下调和趋化功能受损。
  • 2-DG通过抑制ERK磷酸化、促进P38磷酸化降低GRK2表达,从而逆转中性粒细胞CXCR2下调。
  • CXCR2拮抗剂SB225002部分阻断2-DG在脓毒症中的保护作用。

证据类型、等级与局限

  • 证据类型:动物实验与体外细胞实验;原文未报告证据等级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为有氧糖酵解可能是脓毒症的潜在干预靶点;原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Recent evidences suggest that metabolic reprogramming plays an important role in the regulation of innate inflammatory response; however, the specific mechanism is unclear. In this study, we found that glycolytic inhibitor 2-deoxyglucose (2-DG) significantly improved the survival rate in cecal ligation and puncture (CLP)-induced septic mice. 2-DG-treated mice developed increased neutrophil migration to the infectious site and more efficient bacterial clearance than untreated mice. 2-DG reversed the down-regulation of chemokine receptor 2 (CXCR2) and the impaired chemotaxis induced by CLP in mice or lipopolysaccharides (LPS) in human neutrophils. Furthermore, 2-DG reversed the down-regulation of CXCR2 in neutrophils by decreasing the expression of G protein-coupled receptor kinase-2 (GRK2), a serin-threonine protein kinase that mediated the internalization of chemokine receptors, which was induced via the inhibition of extracellular regulated protein kinases (ERK) phosphorylation and the promotion of P38 phosphorylation. Finally, SB225002, a CXCR2 antagonist, partially blocked the protective effects of 2-DG in sepsis. Together, we found a novel mechanism for the migration of neutrophils regulated by metabolism and suggested that aerobic glycolysis might be a potential target of intervention in sepsis.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Tan C, Gu J, Chen H, et al. Inhibition of Aerobic Glycolysis Promotes Neutrophil to Influx to the Infectious Site Via CXCR2 in Sepsis. Shock. 2020. PMID: 30829852. doi:10.1097/SHK.0000000000001334

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。